Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency's Response to the Pandemic.

Ivanov A, Getova-Kolarova V, Hababa-Ivanova I

Open source

DOI
10.3390/pharmacy13060179
Published
2025 Dec 10
Container
Pharmacy (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmacy13060179,
  title = {Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency's Response to the Pandemic.},
  author = {Ivanov A and Getova-Kolarova V and Hababa-Ivanova I},
  year = {2025},
  journal = {Pharmacy (Basel, Switzerland)},
  doi = {10.3390/pharmacy13060179},
  url = {https://doi.org/10.3390/pharmacy13060179}
}

RIS

TY  - JOUR
TI  - Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency's Response to the Pandemic.
AU  - Ivanov A
AU  - Getova-Kolarova V
AU  - Hababa-Ivanova I
PY  - 2025
JO  - Pharmacy (Basel, Switzerland)
DO  - 10.3390/pharmacy13060179
UR  - https://doi.org/10.3390/pharmacy13060179
ER  - 

APA

A, I., V, G., & I, H. (2025). Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency's Response to the Pandemic.. Pharmacy (Basel, Switzerland). https://doi.org/10.3390/pharmacy13060179

Source records